<DOC>
	<DOCNO>NCT02206230</DOCNO>
	<brief_summary>This study do compare standard radiation therapy hypofractionated radiation therapy patient newly diagnose glioblastoma</brief_summary>
	<brief_title>Trial Hypofractionated Radiation Therapy Glioblastoma</brief_title>
	<detailed_description>Hypofractionated radiation therapy ( RT ) treatment patient glioblastoma , 18 - 70 year age good performance status ( ECOG 0 - 2 ) , well tolerated yield survival non-inferior conventional fraction RT , allow significant abbreviation length radiation course require patient limited survival . The importance hypofractionation , therefore , improve survival , rather shorten RT duration improve patient comfort convenience . This approach pertinent give limited life expectancy glioblastoma use patient prolong survival include breast prostate cancer .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<criteria>Newly diagnose , histologically proven intracranial glioblastoma gliosarcoma History physical exam within 14 day prior randomization Between 18 70 year age ECOG 0 2 Stable decrease dose corticosteroid least 14 day prior randomization Prior invasive malignancy unless disease free &gt; 3 year Prior head neck RT ( except glottic cancer ) systemic therapy preclude delivery concurrent adjuvant temozolomide Treatment therapeutic clinical protocol within 30 day prior study registration participation study Specific severe , active comorbidities Not willing able use medically acceptable form contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>glioblastoma</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>hypofractionated radiotherapy</keyword>
</DOC>